This report from Life Science Intelligence provides the latest market data for the Global Neurovascular Interventional Devices for Hemorrhagic Stroke Market. Information covered by this report includes:
This report covers the impact of COVID-19 on the neurovascular interventional devices for hemorrhagic stroke market, including a recent forecast from 2020 to 2025. COVID-19 has also impacted leading competitors, such as Abbott, Boston Scientific, Cardinal Health, Penumbra, Stryker, Terumo, and others. The report provides insights into trends, drivers, and limiters of the neurovascular devices for hemorrhagic stroke market, as well as highlights potential opportunities.
Cordis Cardinal Health